Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-ganglioside compound for targeting cancer and generating antibodies

Anti-ganglioside compound for targeting cancer and generating antibodies

US Patent 10363305 · Granted Jul 30, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carbohydrate structures and uses thereof2023
Treatment using truncated Trk B and Trk C antagonists2021
Intranasal administration of guanidinylated aminoglycosides2020
Treatment using truncated Trk B and Trk C antagonists2018
Intranasal administration of guanidinylated aminoglycosides2017
Beta-turn peptidomimetic cyclic compounds for treating dry eye2017
Inhibitors of p75 receptor and their uses2016
Agonistic antibodies to TrkC receptors and uses thereof2015
Methods of treating retinitis pigmentosa2014
β-turn peptidomimetic cyclic compounds2005
Compositions which are immunologically crossreactive with antibodies and prepara1994